Recent scientific research highlights the crucial role of the endocannabinoid system in protecting against PTSD, a debilitating chronic condition involving horrific memories that cannot be erased. Medical scientists are studying potential PTSD treatments that target the endocannabinoid system.
Bonni Goldstein, MD, spoke to 120 serious, devoted, desperate, courageous parents in Milpitas, CA, on the subject of CBD and Pediatric Epilepsy. “There’s a lot on the internet that’s opinion,” she said, “I’m here to give you the facts.”
“Planning Research for the Next Half a Century” was the title of Raphael Mechoulam’s talk at the International Cannabinoid Research Society (ICRS) meeting in Freiburg, Germany in the summer of 2012.
Concentrated cannabis oil extracts are becoming increasingly popular among self-medicating patients as a claimed cure for many illnesses. Each oil extraction technique has advantages and disadvantages.
Cannabis and its derivatives have been documented for anti-epileptic effects since 1881. Today, the promise of cannabidiol (CBD) as an anti-epileptic treatment is prompting people to move to states that have safe access to medicinal products containing this compound.
The discovery of the endocannabinoid system has breathtaking implications for nearly every area of medicine, spawning a revolution in medical science.
Cannabidiol (CBD) is a phytocannabinoid, with anti-apoptotic, anti-inflammatory and antioxidant effects and has recently been shown to exert a tissue sparing effect during chronic myocardial ischaemia and reperfusion.